RESUMEN
A major genomic alteration in prostate cancer (PCa) is frequent loss of chromosome (chr) 8p with a common region of loss of heterozygosity (LOH) at chr8p22 locus. Genomic studies implicate this locus in the initiation of clinically significant PCa and with progression to metastatic disease. However, the genes within this region have not been fully characterized to date. Here we demonstrate for the first time that a microRNA component of this region-miR-383-is frequently downregulated in prostate cancer, has a critical role in determining tumor-initiating potential and is involved in prostate cancer metastasis via direct regulation of CD44, a ubiquitous marker of PCa tumor-initiating cells (TICs)/stem cells. Expression analyses of miR-383 in PCa clinical tissues established that low miR-383 expression is associated with poor prognosis. Functional data suggest that miR-383 regulates PCa tumor-initiating/stem-like cells via CD44 regulation. Ectopic expression of miR-383 inhibited tumor-initiating capacity of CD44+ PCa cells. Also, 'anti-metastatic' effects of ectopic miR-383 expression were observed in a PCa experimental metastasis model. In view of our results, we propose that frequent loss of miR-383 at chr8p22 region leads to tumor initiation and prostate cancer metastasis. Thus, we have identified a novel finding that associates a long observed genomic alteration to PCa stemness and metastasis. Our data suggest that restoration of miR-383 expression may be an effective therapeutic modality against PCa. Importantly, we identified miR-383 as a novel PCa tissue diagnostic biomarker with a potential that outperforms that of serum PSA.
Asunto(s)
Biomarcadores de Tumor/genética , Receptores de Hialuranos/genética , MicroARNs/genética , Neoplasias de la Próstata/genética , Anciano , Proliferación Celular/genética , Deleción Cromosómica , Cromosomas Humanos Par 8/genética , Regulación Neoplásica de la Expresión Génica , Humanos , Masculino , Persona de Mediana Edad , Pronóstico , Neoplasias de la Próstata/patología , Análisis de SupervivenciaRESUMEN
One of the earliest events in bone morphogenesis is the condensation of embryonic mesenchymal cells into chondroblasts and their subsequent proliferation and differentiation into chondrocytes. During this time, certain signaling cascades operate to establish proper patterning and differentiation of the cartilaginous skeleton. Characterization of the signaling pathways involved in these processes remains to be accomplished. We have identified a novel murine cytosolic tyrosine phosphatase termed PTPPBS gamma (+/-) which is a member of the PTP PC12,Br7,Sl (PTPPBS) family. Spatio-temporal expression analysis of the members of this tyrosine phosphatase family demonstrates significant expression of the gamma (-) splice variant in the cartilaginous skeleton. Using an embryonic mandibular explant culture system to serve as a model for cartilage formation, we examined the potential roles of the PTPPBS gamma phosphatase by loss-of-function studies achieved with antisense oligodeoxynucleotides. These studies demonstrated that loss of expression of the PTPPBS gamma (-) isoform resulted in abnormal patterning of Meckel's cartilage and an increase in the size of the chondrogenic regions. In gamma antisense-treated explants, bromodeoxyuridine-pulse labeling studies revealed increased proliferation of chondroblasts bordering along precartilaginous condensations and bordering populations of maturing chondrocytes. These studies provide evidence that in early skeletal development, PTPPBS gamma may regulate the rate of chondroblast proliferation in the cartilaginous skeleton.
Asunto(s)
Condrogénesis/fisiología , Proteínas Tirosina Fosfatasas/fisiología , Empalme Alternativo , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Tipificación del Cuerpo/genética , Tipificación del Cuerpo/fisiología , Cartílago/embriología , Condrogénesis/genética , ADN/genética , Cartilla de ADN/genética , Regulación del Desarrollo de la Expresión Génica , Regulación Enzimológica de la Expresión Génica , Técnicas In Vitro , Isoenzimas/genética , Isoenzimas/fisiología , Ratones , Datos de Secuencia Molecular , Oligodesoxirribonucleótidos Antisentido/genética , Oligodesoxirribonucleótidos Antisentido/farmacología , Proteínas Tirosina Fosfatasas/genéticaRESUMEN
Protein tyrosine phosphatases (PTPs) play important roles in modulating signals transduced by tyrosine kinases. Certain phosphatases have been implicated as having important roles in embryonic development as well as in adult physiology. Although both kinases and phosphatases are equally important in regulating signal transduction, phosphatases as a group have not been well characterized. Thus, characterization of sequence, expression, and biological function for additional phosphatases is informative. PTPBr7/PC12 and PTPSl are mouse receptor PTPs sharing similar amino acid sequences. Northern blot analysis demonstrated expression of these genes in adult rodent brain and revealed previously uncharacterized transcripts in the brain and other tissues. Our results demonstrate that PTPBr7/PC12 and PTPSl are members of a larger family of PTPs. We have identified two novel family members as well as several novel transcriptional splice variants from both human and mouse colon cDNA libraries. Expression analysis demonstrated that the various mRNA transcripts are differentially expressed, with the highest levels found in the brain, intestinal tract, uterus, and placenta. In situ hybridization analysis of mouse brain and intestinal tissues established that each isoform has a unique expression pattern in specific cell populations as well as in tissue regions. Furthermore, these restricted patterns suggest that the encoded family of phosphatases may play roles in modulating signal transduction pathways important for specific cell types and biological processes.
Asunto(s)
Regulación Enzimológica de la Expresión Génica , Proteínas del Tejido Nervioso/genética , Proteínas Tirosina Fosfatasas/genética , Adulto , Empalme Alternativo/fisiología , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Encéfalo/enzimología , Femenino , Humanos , Hibridación in Situ , Intestinos/enzimología , Péptidos y Proteínas de Señalización Intracelular , Ratones , Datos de Secuencia Molecular , Familia de Multigenes/genética , Especificidad de Órganos , Placenta/enzimología , Biosíntesis de Proteínas , ARN Mensajero/análisis , Proteínas Tirosina Fosfatasas Clase 7 Similares a Receptores , Análisis de Secuencia de ADN , Útero/enzimologíaRESUMEN
Osteoprotegerin (OPG) is a secreted protein that inhibits osteoclast formation. In this study the physiological role of OPG is investigated by generating OPG-deficient mice. Adolescent and adult OPG-/- mice exhibit a decrease in total bone density characterized by severe trabecular and cortical bone porosity, marked thinning of the parietal bones of the skull, and a high incidence of fractures. These findings demonstrate that OPG is a critical regulator of postnatal bone mass. Unexpectedly, OPG-deficient mice also exhibit medial calcification of the aorta and renal arteries, suggesting that regulation of OPG, its signaling pathway, or its ligand(s) may play a role in the long observed association between osteoporosis and vascular calcification.
Asunto(s)
Calcinosis/etiología , Glicoproteínas/deficiencia , Osteoporosis/etiología , Receptores Citoplasmáticos y Nucleares , Enfermedades Vasculares/etiología , Animales , Arterias/patología , Densidad Ósea/genética , Densidad Ósea/fisiología , Calcinosis/patología , Modelos Animales de Enfermedad , Femenino , Marcación de Gen , Glicoproteínas/genética , Glicoproteínas/fisiología , Hibridación in Situ , Masculino , Ratones , Ratones Noqueados , Osteoporosis/patología , Osteoprotegerina , Receptores del Factor de Necrosis Tumoral , Enfermedades Vasculares/patologíaRESUMEN
A novel secreted glycoprotein that regulates bone resorption has been identified. The protein, termed Osteoprotegerin (OPG), is a novel member of the TNF receptor superfamily. In vivo, hepatic expression of OPG in transgenic mice results in a profound yet nonlethal osteopetrosis, coincident with a decrease in later stages of osteoclast differentiation. These same effects are observed upon administration of recombinant OPG into normal mice. In vitro, osteoclast differentiation from precursor cells is blocked in a dose-dependent manner by recombinant OPG. Furthermore, OPG blocks ovariectomy-associated bone loss in rats. These data show that OPG can act as a soluble factor in the regulation of bone mass and imply a utility for OPG in the treatment of osteoporosis associated with increased osteoclast activity.
Asunto(s)
Densidad Ósea/fisiología , Glicoproteínas/fisiología , Osteoclastos/efectos de los fármacos , Osteopetrosis/genética , Receptores Citoplasmáticos y Nucleares , Secuencia de Aminoácidos , Animales , Resorción Ósea , Diferenciación Celular/efectos de los fármacos , Células Cultivadas , Cricetinae , Femenino , Regulación del Desarrollo de la Expresión Génica , Glicoproteínas/genética , Glicoproteínas/metabolismo , Glicoproteínas/farmacología , Humanos , Hígado/metabolismo , Masculino , Ratones , Ratones Transgénicos , Datos de Secuencia Molecular , Especificidad de Órganos , Osteoclastos/citología , Osteopetrosis/metabolismo , Osteoprotegerina , Ovariectomía , ARN Mensajero/análisis , Ratas , Ratas Endogámicas F344 , Receptores del Factor de Necrosis Tumoral , Proteínas Recombinantes de Fusión , Homología de Secuencia de AminoácidoRESUMEN
The 2;5 chromosomal translocation is frequently associated with anaplastic large cell lymphomas (ALCLs). The translocation creates a fusion gene consisting of the alk (anaplastic lymphoma kinase) gene and the nucelophosmin (npm) gene: the 3' half of alk derived from chromosome 2 is fused to the 5' portion of npm from chromosome 5. A recent study shows that the product of the npm-alk fusion gene is oncogenic. To help understand how the npm-alk oncogene transform cells, it is important to investigate the normal biological function of the alk gene product, ALK. Here, we show molecular cloning of cDNAs for both the human and mouse ALK proteins. The deduced amino acid sequences reveal that ALK is a novel receptor protein-tyrosine kinase having a putative transmembrane domain and an extracellular domain. These sequences are absent in the product of the transforming npm-alk gene. ALK shows the greatest sequence similarity to LTK (leukocyte tyrosine kinase) whose biological function is presently unknown. RNA blot hybridization analysis of various tissues reveals that the alk mRNA is dominantly detected in the brain and spinal cord. Immunoblotting with anti-ALK antibody shows that ALK is highly expressed in the neonatal brain. Furthermore, RNA in situ hybridization analysis shows that the alk mRNA is dominantly expressed in neurons in specific regions of the nervous system such as the thalamus, mid-brain, olfactory bulb, and ganglia of embryonic and neonatal mice. These data suggest that ALK plays an important role(s) in the development of the brain and exerts its effects on specific neurons in the nervous system.
Asunto(s)
Encéfalo/metabolismo , Neuronas/metabolismo , Proteínas Tirosina Quinasas/biosíntesis , Proteínas Tirosina Quinasas/genética , Médula Espinal/metabolismo , Secuencia de Aminoácidos , Quinasa de Linfoma Anaplásico , Animales , Animales Recién Nacidos , Secuencia de Bases , Encéfalo/embriología , Cromosomas Humanos Par 2 , Cromosomas Humanos Par 5 , Clonación Molecular , ADN Complementario , Embrión de Mamíferos , Ganglios/embriología , Ganglios/metabolismo , Expresión Génica , Biblioteca de Genes , Humanos , Hibridación in Situ , Masculino , Ratones , Datos de Secuencia Molecular , Proteínas Nucleares/biosíntesis , Proteínas Nucleares/genética , Nucleofosmina , Especificidad de Órganos , Proteínas Tirosina Quinasas/química , Proteínas Tirosina Quinasas Receptoras , Proteínas Recombinantes de Fusión/biosíntesis , Proteínas Recombinantes de Fusión/química , Homología de Secuencia de Aminoácido , Médula Espinal/embriología , Testículo/metabolismo , Translocación GenéticaRESUMEN
Expression of human keratinocyte growth factor (KGF/FGF-7) was directed to hepatocytes during the later period of mouse gestation using a human apolipoprotein E (ApoE) gene promoter and its associated liver-specific enhancer. Human KGF was detectable in liver extracts and serum prepared from e17.5-e19.5 embryos, concomitant with the appearance of morphological abnormalities in several organs which express KGF receptor. The most striking phenotypic aberration in the ApoE-hKGF transgenic embryos was marked hyperplasia and cystic dilation of the cortical and medullary kidney collecting duct system, a phenotype resembling infantile polycystic kidney disease in humans. Transgenic embryos had enlarged livers, with prominent biliary epithelial hyperplasia, and also exhibited enhanced bronchiolar epithelial and type II pneumocyte proliferation. There was variable hyperplasia of intestinal epithelia, and urothelium of the urinary bladder and ureters. When compared to age-matched littermate controls, marked epidermal papillomatous acanthosis and hyperkeratosis in the skin, with a notable decrease in the number of developing hair follicles was seen in transgenic embryos. The pancreas exhibited significant ductal hyperplasia, with an increase in the number of ductal epithelial cells staining positive for insulin expression. High systemic levels of KGF during the latter stages of embryogenesis causes abnormalities in epithelial growth and differentiation within multiple organ systems and results in perinatal lethality. Correct temporal and spatial expression of KGF during the latter stages of organ development is likely to play a critical role in mesenchymal-epithelial signaling required for normal embryonic growth and development.
Asunto(s)
Anomalías Congénitas/etiología , Factores de Crecimiento de Fibroblastos , Sustancias de Crecimiento/fisiología , Hígado/embriología , Hígado/fisiología , Enfermedades Renales Poliquísticas/etiología , Animales , Apolipoproteínas E/genética , Diferenciación Celular/fisiología , División Celular/fisiología , Anomalías Congénitas/genética , Células Epiteliales , Epitelio/crecimiento & desarrollo , Factor 10 de Crecimiento de Fibroblastos , Factor 7 de Crecimiento de Fibroblastos , Expresión Génica , Sustancias de Crecimiento/biosíntesis , Sustancias de Crecimiento/genética , Humanos , Inmunohistoquímica , Hígado/metabolismo , Pulmón/anomalías , Pulmón/citología , Ratones , Ratones Endogámicos , Ratones Transgénicos , Enfermedades Renales Poliquísticas/genética , Enfermedades Renales Poliquísticas/patología , Regiones Promotoras Genéticas/fisiología , ARN Mensajero/metabolismo , TransgenesRESUMEN
Neuregulins are ligands for the erbB family of receptor tyrosine kinases and mediate growth and differentiation of neural crest, muscle, breast cancer, and Schwann cells. Neuregulins contain an epidermal growth factor-like domain located C-terminally to either an Ig-like domain or a cysteine-rich domain specific to the sensory and motor neuron-derived isoform. Here it is shown that elimination of the Ig-like domain-containing neuregulins by homologous recombination results in embryonic lethality associated with a deficiency of ventricular myocardial trabeculation and impairment of cranial ganglion development. The erbB receptors are expressed in myocardial cells and presumably mediate the neuregulin signal originating from endocardial cells. The trigeminal ganglion is reduced in size and lacks projections toward the brain stem and mandible. We conclude that IgL-domain-containing neuregulins play a major role in cardiac and neuronal development.
Asunto(s)
Nervios Craneales/embriología , Corazón Fetal/embriología , Glicoproteínas/fisiología , Animales , Secuencia de Bases , Nervios Craneales/anomalías , Cartilla de ADN/genética , Femenino , Corazón Fetal/anomalías , Marcación de Gen , Glicoproteínas/química , Glicoproteínas/genética , Inmunoglobulinas/química , Inmunoglobulinas/genética , Inmunohistoquímica , Hibridación in Situ , Masculino , Ratones , Ratones Endogámicos C57BL , Datos de Secuencia Molecular , Mutación , Neurregulinas , ARN Mensajero/genética , ARN Mensajero/metabolismoRESUMEN
Expression of human keratinocyte growth factor (KGF/FGF-7) was directed to epithelial cells of the developing embryonic lung of transgenic mice disrupting normal pulmonary morphogenesis during the pseudoglandular stage of development. By embryonic day 15.5(E15.5), lungs of transgenic surfactant protein C (SP-C)-KGF mice resembled those of humans with pulmonary cystadenoma. Lungs were cystic, filling the thoracic cavity, and were composed of numerous dilated saccules lined with glycogen-containing columnar epithelial cells. The normal distribution of SP-C proprotein in the distal regions of respiratory tubules was disrupted. Columnar epithelial cells lining the papillary structures stained variably and weakly for this distal respiratory cell marker. Mesenchymal components were preserved in the transgenic mouse lungs, yet the architectural relationship of the epithelium to the mesenchyme was altered. SP-C-KGF transgenic mice failed to survive gestation to term, dying before E17.5. Culturing mouse fetal lung explants in the presence of recombinant human KGF also disrupted branching morphogenesis and resulted in similar cystic malformation of the lung. Thus, it appears that precise temporal and spatial expression of KGF is likely to play a crucial role in the control of branching morphogenesis during fetal lung development.
Asunto(s)
Cistoadenoma/genética , Factores de Crecimiento de Fibroblastos , Sustancias de Crecimiento/biosíntesis , Neoplasias Pulmonares/genética , Pulmón/embriología , Animales , Biomarcadores/análisis , Cistoadenoma/metabolismo , Cistoadenoma/patología , Desarrollo Embrionario y Fetal , Muerte Fetal , Factor 10 de Crecimiento de Fibroblastos , Factor 7 de Crecimiento de Fibroblastos , Edad Gestacional , Sustancias de Crecimiento/genética , Humanos , Pulmón/patología , Neoplasias Pulmonares/metabolismo , Neoplasias Pulmonares/patología , Ratones , Ratones Transgénicos , Regiones Promotoras Genéticas , Proteolípidos/genética , Surfactantes Pulmonares/genética , ARN Mensajero/análisis , ARN Mensajero/biosíntesisRESUMEN
The human apolipoprotein (apo) E and apoC-I genes are located 5 kilobases apart in the same transcriptional orientation on chromosome 19, and they are expressed at high levels in the liver with lower levels of expression in selected other tissues. Analysis of a series of overlapping human apoE and apoC-I genomic fragments in transgenic mice revealed that the expression of these transgenes in the liver requires a common cis-acting regulatory domain. This hepatic control region (HCR) was localized to a 764-base pair region that is located about 18 kilobases downstream of the apoE promoter and about 9 kilobases downstream of the apoC-I promoter. All the transgenic animals that had been prepared with a construct that contained this region had relatively high levels of transgene expression in the liver, whereas constructs that lacked this region showed no expression in the liver. In situ hybridization studies showed that the HCR directed apoE and apoC-I transgene expression in hepatocytes. When the HCR from the apoE/C-I gene locus was ligated proximal to a human apoA-IV gene fragment, which is not normally expressed in the liver, the resulting apoA-IV/HCR fusion construct was expressed at high levels in the liver, indicating that the HCR could direct high level liver expression of a heterologous promoter/gene construct. Expression of the apoE transgene in the liver and kidney, and perhaps other tissues, required the presence of a nonspecific proximal enhancer element in the apolipoprotein E gene promoter, located between 161 and 141 bp relative to the transcription initiation site. However, the proximal apoE gene promoter, including this enhancer element, contained no sequences capable of directing hepatocyte expression in the absence of the HCR. Thus, the far-downstream HCR appears to contain all of the sequences necessary for determining high level liver-specific gene expression.
Asunto(s)
Apolipoproteínas C/genética , Apolipoproteínas E/genética , Cromosomas Humanos Par 19 , Regulación de la Expresión Génica , Hígado/metabolismo , Animales , Elementos sin Sentido (Genética) , Apolipoproteína C-I , Apolipoproteínas C/biosíntesis , Apolipoproteínas E/biosíntesis , Elementos de Facilitación Genéticos , Humanos , Hibridación in Situ , Riñón/metabolismo , Masculino , Ratones , Ratones Transgénicos , Especificidad de Órganos , Regiones Promotoras Genéticas , ARN/genética , ARN/aislamiento & purificación , Sondas ARN , ARN Mensajero/análisis , ARN Mensajero/genética , Mapeo RestrictivoRESUMEN
To investigate the mechanisms controlling tissue-specific expression of the human apolipoprotein (apo) E/C-I gene locus, human apoE and apoC-I gene constructs containing various lengths of the 5'-flanking or 3'-flanking region were used to create transgenic mice. Several essential tissue-specific regulatory elements were identified in the region between the apoE and the apoC-I genes, as well as in a distal domain found downstream of the apoC-I gene. Most notably, transcription of both the apoE and apoC-I genes in the liver, their major site of expression, required downstream regulatory elements, possibly located within a common regulatory domain more than 2 kilobases 3' of the apoC-I gene (about 14 kilobases downstream of the apoE gene promoter). In the region between the apoE and apoC-I genes, a single strong positive element directed apoE and apoC-I gene expression in the skin. The intergenic region also contained elements that stimulated apoE gene expression in the brain and silenced apoE gene expression only in the kidney. These results demonstrate that multiple independent regulatory elements control expression of the human apoE/C-I gene locus in various tissues. Transgenic mice expressing human apoC-I in the liver exhibited plasma triglyceride levels that were 2-3-fold higher than those in control mice, an effect not found when transgenic human apoE was produced. This result suggests that apoC-I may modulate the metabolism of triglyceride-rich lipoproteins.
Asunto(s)
Apolipoproteínas C/genética , Apolipoproteínas E/genética , Regulación de la Expresión Génica , Animales , Apolipoproteína C-I , Colesterol/sangre , Genes , Humanos , Hígado/fisiología , Ratones , Ratones Transgénicos , ARN Mensajero/genética , Secuencias Reguladoras de Ácidos Nucleicos , Fenómenos Fisiológicos de la Piel , Triglicéridos/sangreRESUMEN
Human apolipoprotein (apo) E gene constructs with 30 or 5 kilobases of 5'-flanking and 1.5 kilobases of 3'-flanking regions were used to create transgenic mice. High levels of human apoE mRNA were present in the transgenic kidney, but none was detected in the liver, which is normally the major source of apoE. When a construct with 5 kilobases of 5'- and 23 kilobases of 3'-flanking regions was used, only trace levels of human apoE mRNA were detected in the kidney, whereas high levels were found in the liver. These results indicated that regulatory elements downstream of the human apoE gene interacted with the transcription initiation complex to stimulate gene expression in the liver while suppressing expression in the kidney. In each case, human apoE was secreted into the plasma. The source of human apoE in the transgenic kidney was the epithelial cells lining the proximal tubule and Bowman's capsule.
Asunto(s)
Apolipoproteínas E/genética , Expresión Génica , Riñón/metabolismo , Animales , Clonación Molecular , ADN Recombinante , Humanos , Técnicas para Inmunoenzimas , Hígado/metabolismo , Masculino , Ratones , Ratones Endogámicos ICR , Ratones Transgénicos , Hibridación de Ácido Nucleico , Sondas ARN , ARN Mensajero/análisis , Secuencias Reguladoras de Ácidos Nucleicos , Piel/análisis , Testículo/análisis , Distribución Tisular , Transcripción GenéticaAsunto(s)
Apolipoproteínas E/genética , Genes Reguladores , Animales , Apolipoproteínas E/biosíntesis , Cósmidos , Femenino , Regulación de la Expresión Génica , Humanos , Inmunohistoquímica , Riñón/metabolismo , Hígado/metabolismo , Masculino , Ratones , Ratones Endogámicos ICR , Ratones Transgénicos , Embarazo , ARN Mensajero/genética , ARN Mensajero/metabolismo , Distribución TisularRESUMEN
The M gene of bovine papillomavirus type 1 has been genetically defined as encoding a trans-acting product which negatively regulates bovine papillomavirus type 1 replication and is important for establishment of stable plasmids in transformed cells. The gene for this regulatory protein has been mapped in part to the 5' portion of the largest open reading frame (E1) in the virus. We constructed a trpE-E1 fusion gene and expressed this gene in Escherichia coli. Rabbits were immunized with purified fusion protein, and antisera directed against the product were used to identify the M gene product in virus-transformed cells. In this way a polypeptide with an apparent molecular mass of 23 kilodaltons was detected. The virus-encoded product is phosphorylated and can be readily detected by immunoprecipitation assays from cells transformed by the virus. Cells that harbor viral DNA without M as integrated copies do not produce this protein, whereas cells that harbor integrated viral genomes which are defective for another E1 viral gene important for plasmid replication, R, do produce this protein. The protein has an anomalously low electrophoretic mobility. An in vitro translation product of an SP6 RNA product of a sequenced cDNA predicts a molecular mass of 16 kilodaltons for the protein, and this in vitro translation product has an electrophoretic mobility identical to that of the in vivo immunoprecipitated protein. The results of these studies confirm our previous genetic studies which indicated that part of the E1 open reading frame defined a discrete gene product distinct from other putative products which may be encoded by this open reading frame.